Close
Smartlab Europe
Inizio Ignite

News

Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes

Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results from Eli Lilly and Company's SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety...

Merck Expands Life Science Production Capacities in the United States

Merck, a leading science and technology company, announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. These sites supply critical products to...

Aizon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing

Based on its recent analysis of the North American artificial intelligence (AI) market for productivity and compliance in pharmaceuticals, Frost & Sullivan recognizes Aizon with the 2020 North American Enabling Technology Leadership Award. Aizon's good practice (GxP)-compliant, cloud-based, and...

CluePoints Opens New AsiaPac Office in Tokyo

CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients,...

Piramal Pharma Solutions invests US$ 32 mn to expand Michigan facility

Piramal Pharma Limited’s pharma solutions business, a leading contract development and manufacturing organization (CDMO), is investing US$ 32 million to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharmaceutical...

U.S. FDA confirms Pfizer COVID vaccine safe & effective

The FDA 53-page briefing document gives a green signal to Pfizer-BioNTech COVID-19 vaccine. A US roll-out of the vaccine is expected post-approval from an outside panel of scientific advisers who will review the FDA report on Thursday. As COVID cases...

UK Begins The Biggest Immunization Program In Its History

The UK has begun immunizing citizens against Coronavirus. Population above 80, the most vulnerable and the front line health care workers to be administered with the Pfizer COVID-19 vaccine in the first phase. There is a history in the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »